Results 81 to 90 of about 16,685 (240)
Polymyalgia rheumatica: An updated review.
Polymyalgia rheumatica should be suspected in older patients with bilateral shoulder and hip stiffness that is worse in the morning and improves with use.
S. Mahmood +3 more
semanticscholar +1 more source
ABSTRACT The use of immune checkpoint inhibitors (ICIs) has significantly improved the efficacy of cancer therapy, but their associated immune‐related adverse events (irAEs) can severely compromise treatment safety. This review systematically summarizes the core mechanisms underlying irAEs, which include multi‐organ damage resulting from T‐cell ...
Anqi Lin +8 more
wiley +1 more source
ABSTRACT Objective Autoimmunity can be part of the pathogenesis of polycystic ovary syndrome (PCOS), but prospective studies on autoimmune disease in population based cohorts are lacking. This study aimed to investigate incidence rates of autoimmune disease in Danish women with PCOS before and after PCOS diagnosis compared to controls.
Dorte Glintborg +4 more
wiley +1 more source
Polymyalgia Rheumatica (PMR) Lacking Shoulder Pain Following COVID-19 Vaccination [PDF]
Kotaro Haruna +2 more
openalex +1 more source
Large vessel vasculitis (LVV) is defined as a disease mainly affecting the large arteries, with two major variants, Takayasu arteritis (TA) and giant cell arteritis (GCA).
R. Slart +51 more
semanticscholar +1 more source
Features of polymyalgia rheumatica–like syndrome after immune checkpoint inhibitor therapy
We read with great interest the article published by Braaten and colleagues1 describing inflammatory arthritis (IA) induced by immune checkpoint inhibitors (ICIs) persisting after immunotherapy cessation.
Grégoire Martin de Frémont +7 more
semanticscholar +1 more source
Markers of Giant Cell Arteritis in Patients Presenting With Ischemic Stroke: A Scoping Review
Giant cell arteritis should be considered in patients aged ≥ 50 years presenting with vertebrobasilar ischemic events, multifocal infarcts affecting both vertebrobasilar and carotid territories, or recurrent ischemic events despite optimal secondary prevention.
Alain‐Mauricio Vergara +5 more
wiley +1 more source
Features of early diagnosis and treatment of polymyalgia rheumatic (PMR)
RELAVANCE. Early diagnosis of PMR is important, since the duration of treatment and the outcome of the disease depend on it. W. Bruce, 1888 called PMR "prussic rheumatic gout" and only Barber, 1957 ― polymyalgia rheumatica.
V. T. Komarov +3 more
doaj +1 more source
Objective To assess whether the polymyalgia rheumatica (PMR)-like syndrome reported as an immune related adverse event (irAE) from checkpoint inhibitor therapy is consistent with the 2012 European League Against Rheumatism (EULAR)/American College of ...
C. Calabrese +5 more
semanticscholar +1 more source

